Influenza susceptibility, severity, and shedding in HIV-infected adults: a review of the literature.

Influenza is a common cause of respiratory illness in adults infected with human immunodeficiency virus (HIV), but current knowledge about seasonal and 2009 H1N1 pandemic influenza A (H1N1pdm) virus infections in HIV-infected persons is limited. In this paper, we review the existing literature regarding influenza susceptibility, severity, and shedding in HIV-infected adults. Data show HIV infection does not significantly increase susceptibility to influenza. AIDS is associated with greater seasonal influenza-related morbidity and mortality, but the risk associated with HIV infection among those with less immune suppression is largely unknown. Immunologic compromise has been shown to increase the magnitude and duration of influenza virus shedding; however, these studies are limited within HIV-infected populations. With regards to H1N1pdm, data are even more limited. Reports raise concern of increased severity among HIV-infected persons, although this may be driven by other comorbid illnesses. Prospective studies are needed among HIV-infected persons to more definitively investigate influenza susceptibility, severity, and shedding.

[1]  J. Skarbinski,et al.  HIV-infected hospitalized patients with 2009 pandemic influenza A (pH1N1)--United States, spring and summer 2009. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  Y. Leo,et al.  Pandemic (H1N1) 2009 influenza in HIV-infected adults: clinical features, severity, and outcome. , 2010, The Journal of infection.

[3]  G. Hill-Cawthorne,et al.  Oseltamivir-Resistant Pandemic (H1N1) 2009 in Patient with Impaired Immune System , 2010, Emerging infectious diseases.

[4]  H. A. Cook,et al.  Fatalities associated with the 2009 H1N1 influenza A virus in New York city. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  I. Bonmarin,et al.  Severe hospitalised 2009 pandemic influenza A(H1N1) cases in France, 1 July-15 November 2009. , 2010, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[6]  C. C. van den Wijngaard,et al.  Surveillance of hospitalisations for 2009 pandemic influenza A(H1N1) in the Netherlands, 5 June - 31 December 2009. , 2010, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[7]  J. C. Carmona,et al.  Behaviour of the pandemic H1N1 influenza virus in Andalusia, Spain, at the onset of the 2009-10 season. , 2009, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[8]  Lyn Finelli,et al.  Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. , 2009, The New England journal of medicine.

[9]  J. Martin,et al.  Surveillance of the first 205 confirmed hospitalised cases of pandemic H1N1 influenza in Ireland, 28 April - 3 October 2009. , 2009, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[10]  Robert Schechter,et al.  Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. , 2009, JAMA.

[11]  S. Lapinsky,et al.  Critically Ill patients with 2009 influenza A(H1N1) in Mexico. , 2009, JAMA.

[12]  M. Meade,et al.  Critically ill patients with 2009 influenza A(H1N1) infection in Canada. , 2009, JAMA.

[13]  L. Filleul,et al.  Preliminary analysis of the pandemic H1N1 influenza on Reunion Island (Indian Ocean): surveillance trends (July to mid-September 2009). , 2009, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[14]  G. Penna,et al.  Pandemic H1N1 influenza in Brazil: analysis of the first 34,506 notified cases of influenza-like illness with severe acute respiratory infection (SARI). , 2009, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[15]  G. Chowell,et al.  Pandemic influenza in a southern hemisphere setting: the experience in Peru from May to September, 2009. , 2009, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[16]  A. Gilsdorf,et al.  Influenza A(H1N1)v in Germany: the first 10,000 cases. , 2009, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[17]  P. Barboza,et al.  Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009. , 2009, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[18]  J. Sung,et al.  Viral Loads and Duration of Viral Shedding in Adult Patients Hospitalized with Influenza , 2009, The Journal of infectious diseases.

[19]  M. Jonges,et al.  Prolonged influenza virus infection during lymphocytopenia and frequent detection of drug-resistant viruses. , 2009, The Journal of infectious diseases.

[20]  Gerry Barber,et al.  Oseltamivir-resistant novel influenza A (H1N1) virus infection in two immunosuppressed patients - Seattle, Washington, 2009. , 2009, MMWR. Morbidity and mortality weekly report.

[21]  Melissa R. Pfeiffer,et al.  Population prevalence of reported and unreported HIV and related behaviors among the household adult population in New York City, 2004 , 2008, AIDS.

[22]  G. Boivin,et al.  Influenzavirus infection is a primary cause of febrile respiratory illness in HIV-infected adults, despite vaccination. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  F. Ansaldi,et al.  An outbreak of influenza in a residential drug‐rehabilitation community , 2006, Journal of medical virology.

[24]  F. Hayden,et al.  Recovery of drug-resistant influenza virus from immunocompromised patients: a case series. , 2006, The Journal of infectious diseases.

[25]  S. Oka,et al.  Efficacy and Immunologic Responses to Influenza Vaccine in HIV-1-Infected Patients , 2005, Journal of acquired immune deficiency syndromes.

[26]  A. Pontiroli,et al.  Impact of influenza vaccine on response to vaccination with pneumococcal vaccine in HIV patients. , 2005, AIDS research and human retroviruses.

[27]  N. Benowitz,et al.  Cigarette smoking and infection. , 2004, Archives of internal medicine.

[28]  K. Neuzil,et al.  Cardiopulmonary Hospitalizations During Influenza Season in Adults and Adolescents With Advanced HIV Infection , 2003, Journal of acquired immune deficiency syndromes.

[29]  L. Gubareva,et al.  Prolonged shedding of multidrug-resistant influenza A virus in an immunocompromised patient. , 2003, The New England journal of medicine.

[30]  G. Boivin,et al.  Prolonged excretion of amantadine-resistant influenza a virus quasi species after cessation of antiviral therapy in an immunocompromised patient. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  M. Rosen,et al.  Pulmonary complications of HIV infection. Report of the Fourth NHLBI Workshop. , 2001, American journal of respiratory and critical care medicine.

[32]  D. Skiest,et al.  Clinical manifestations of influenza in HIV-infected individuals , 2001, International journal of STD & AIDS.

[33]  C. Bridges,et al.  Influenza A among patients with human immunodeficiency virus: an outbreak of infection at a residential facility in New York City. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[34]  K. Nichol,et al.  Excess mortality due to pneumonia or influenza during influenza seasons among persons with acquired immunodeficiency syndrome. , 2001, Archives of internal medicine.

[35]  Lihan K. Yan,et al.  Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults. , 2000, The Journal of infectious diseases.

[36]  N. Franck,et al.  Influenza in Human Immunodeficiency Virus-Infected Patients during the 1997-1998 Influenza Season , 2000 .

[37]  P. Ward,et al.  Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment. , 1999, JAMA.

[38]  K. Neuzil,et al.  Influenza-associated morbidity and mortality in young and middle-aged women. , 1999, JAMA.

[39]  A. Kaplan,et al.  Effects of influenza vaccination in HIV-infected adults: a double-blind, placebo-controlled trial. , 1998, Vaccine.

[40]  W. Green,et al.  Pulmonary complications of HIV infection: autopsy findings. , 1998, Chest.

[41]  N. Cox,et al.  Prolonged shedding of amantadine-resistant influenzae A viruses by immunodeficient patients: detection by polymerase chain reaction-restriction analysis. , 1995, The Journal of infectious diseases.

[42]  L. Markson,et al.  Duration of Medicaid AIDS hospitalizations--variation by season, stage, and year. , 1992, American journal of public health.

[43]  J. Mills,et al.  Influenza in patients with human immunodeficiency virus infection. , 1990, Chest.

[44]  J. Thurn,et al.  Influenza A pneumonitis in a patient infected with the human immunodeficiency virus (HIV). , 1989, Chest.

[45]  J. Cohen,et al.  Susceptibility to influenza A in HIV-positive patients. , 1989, JAMA.

[46]  Increase in Pneumonia Mortality Among Young Adults and the HIV Epidemic , 1989, MMWR. Morbidity and mortality weekly report.

[47]  Leads from the MMWR. Increase in pneumonia mortality among young adults and the HIV epidemic--New York City, United States. , 1988, JAMA.